GaudiBio is a Precision Medicine 2
GaudiBio is a Precision Medicine 2.0 biotechnology company redefining CNS drug development through a precision-medicine platform that identifies and addresses the causes of rare neurological diseases using genomics, patient-derived cells, and organoids. The company's mission is to unleash the genome to cure disease—one patient at a time—by translating deep biological insight into clinically actionable therapies faster and with lower development risk.